AbbVie After Purchase Apogee? Is It a Buy Now for Investors
AbbVie is expanding its immunology portfolio with Apogee Therapeutics. This guide explains what the deal adds, how it...
What are the steps in personal finance planning? Knowing these can help you create a solid foundation for your financial future.
19,956 articlesAbbVie is expanding its immunology portfolio with Apogee Therapeutics. This guide explains what the deal adds, how it...
The FIFA World Cup is fueling a new wave of activity in prediction markets. Kalshi is riding that momentum, turning t...
South Korea’s Kiwoom Securities is nearing a deal to take a minority stake in Bithumb, signaling growing institutiona...
Hometap expands its home equity investment offering to Georgia, Montana, Tennessee, Idaho, and Delaware, signaling co...
Robinhood Chain goes live on mainnet, delivering Layer 2 scalability for tokenized assets and a suite of around-the-c...
As 2026 unfolds, investors debate whether ripple worth holding through the year hinges on regulatory clarity, adoptio...
The IDX framework sits at the center of a pivotal industry debate as market power concentrates and data becomes a str...
Bond traders pulled back on AI-linked notes after Amazon revealed a new $25 billion borrowing plan, triggering a broa...
Despite a record number of crypto attacks in H1 2026, total losses slipped under $1 billion, signaling a shift in ris...
CoreWeave’s billion funding haul underscores a shifting liquidity landscape, with AI infrastructure drawing tens of b...
Nvidia dominates today’s AI data centers, but the real threat to its throne may be a risk that sits in plain sight. T...
Citigroup is up about 14% year-to-date through mid-July 2026, outpacing Bank of America and Wells Fargo. AI-driven tr...